PhD Opportunity in Cancer Cell Division: The Tolić Lab at the Ruđer Bošković Institute (Zagreb, Croatia) invites applications for a fully funded PhD position focused on understanding how cancer cells survive and decide between life and death during cell division. This position offers an exceptional opportunity to work in a highly interdisciplinary and internationally connected research environment at the forefront of cell biology and cancer research.
PhD Scholarship Opportunity in Cancer Cell Division – Tolić Lab, Ruđer Bošković Institute
Designation
PhD Student / Doctoral Researcher
Research Area
- Cell Biology
- Cancer Biology
- Mitosis and Cell Division
- Biophysics
- Live-cell Microscopy
- Genetics and Molecular Biology
- Genomics, Proteomics, Bioinformatics, and Computational Modeling (collaborative)
Location
Tolić Lab
Ruđer Bošković Institute
Zagreb, Croatia
(With collaborations across Croatia, the Netherlands, Germany, Denmark, and Switzerland)
Eligibility / Qualification
- Strong interest in cell biology, cancer research, or biophysics
- Background in life sciences or related fields (e.g., biology, biotechnology, biophysics, molecular biology)
- Curiosity, motivation, and willingness to work in an interdisciplinary research environment
- Ability to collaborate in an international research network
Job Description
The selected PhD student will investigate how cancer cells maintain resilience when errors occur during cell division. The research will integrate experimental and collaborative approaches, including:
- Live-cell microscopy
- Genetic and molecular biology techniques
- Interaction with genomics, proteomics, bioinformatics, and modeling experts
- Participation in a dynamic, interdisciplinary, and international research network
The project aims to generate insights that could reshape current understanding of mitosis and cancer.
How to Apply
Interested candidates should send:
- A detailed CV
- A short motivation letter
Email: tolic@irb.hr
For more information about the lab, visit: tolic.irb.hr
Last Date for Apply
March 1, 2026
